EichorEICHOR
Location: Buenos Aires Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Buenos Aires

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Asociación de Beneficencia Hospital Sirio Libanés · Pfizer · NCT07028853Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Hospital Italiano de Buenos Aires · Daiichi Sankyo · NCT07022483Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Asociación de Beneficencia Hospital Sirio Libanés · Bristol-Myers Squibb · NCT07106762Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Hospital Británico de Buenos Aires-Oncology ( Site 0502) · Merck Sharp & Dohme LLC · NCT06393374International Prospective REgistry on Pre-pectorAl Breast REconstruction
Phase N/A · Univesidad de Buenos Aires · IRCCS San Raffaele · NCT05817175This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Fundación Respirar · Pfizer · NCT06758401A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · Expertia S.A- Mautalén Salud e Investigación · H. Lundbeck A/S · NCT05897320Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Phase 1/Phase 2 · Hosp. General de Agudos Buenos Aires Argentina NICHD CRS · National Institute of Allergy and Infectious Diseases (NIAID · NCT02140255A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hospital Aleman de Buenos Aires · Hoffmann-La Roche · NCT06793215A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Merck Sharp & Dohme LLC · NCT07216703A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Hospital Italiano de Buenos Aires · Bayer · NCT07192952A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 2 · Merck Sharp & Dohme LLC · NCT06077760Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Hospital Italiano de Buenos Aires · Gilead Sciences · NCT06051617Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · Hospital Italiano de Buenos Aires · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait
NA · Hospital Italiano de Buenos Aires · Hospital Alemão Oswaldo Cruz · NCT05000697A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to
Phase 3 · Local Institution - 0062 · Bristol-Myers Squibb · NCT04877288To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiv
Phase 2 · Hospital Italiano de Buenos Aires · Incyte Corporation · NCT05090891A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-0
Phase 3 · Hospital Italiano de Buenos Aires ( Site 0253) · Merck Sharp & Dohme LLC · NCT07489495Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Phase 2/Phase 3 · IADIN (Instituto Argentino de Investigación Neurológica) · Skyhawk Therapeutics, Inc. · NCT07378644A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Organización Médica de Investigación · Biogen · NCT06962800A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Terapia Renal Domiciliaria · Boehringer Ingelheim · NCT07220083A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Instituto Alexander Fleming ( Site 0306) · Merck Sharp & Dohme LLC · NCT06833073Cryotherapy Versus Standard Care in Reducing Opioid Consumption After Total Knee Arthroplasty
NA · Hospital Italiano de Buenos Aires · Hospital Italiano de Buenos Aires · NCT07630337Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semagluti
Phase N/A · Hospital Italiano de Buenos Aires · Hospital Italiano de Buenos Aires · NCT07621419A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 2 · Merck Sharp & Dohme LLC · NCT06623422A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplic · Takeda · NCT06963827A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Cemic /Id# 231486 · AbbVie · NCT04928846Argentinean Registry on the Management of Helicobacter Pylori Infection
Phase N/A · Instituto de Investigaciones Medicas Alfredo Lanari. Univers · University of Buenos Aires · NCT06579365A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · Buenos Aires Investigative Site FIN-20031 · Colorado Prevention Center · NCT06033950Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder
Phase 2 · Hospital Italiano de Buenos Aires (HIBA) · Protara Therapeutics · NCT05951179
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.